SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Value (MSEK)
227,0

Board

CEO

  • Ann Gidner

Chairman Of The Board

  • Catharina Svanborg

Board

  • Carl-Johan Wachtmeister
  • Gabriela Godaly
  • Helena Lomberg

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 45,75 73,29 2021-03-31
FV Group AB 6,42 3,16 2021-03-31
Nordnet Pensionsförsäkring 4,89 2,41 2021-03-31
Avanza Pension 4,29 2,11 2021-03-31
Jan Zetterberg 3,25 1,60 2021-03-31
Helena Lomberg 1,49 0,74 2021-03-31
Swedbank Försäkring 1,24 0,61 2021-03-31
Monica Strömberg 1,09 0,54 2021-03-31
Fredrik Herslow 0,82 0,40 2021-03-31
Mikael Hägg 0,57 0,28 2021-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2021-05-25 Delårsrapport 2021-Q3

  • 2021-08-31 Bokslutskommuniké 2021